RA Messages for October 19, 1999


PHARMACY PROVIDERS, PLEASE NOTE!!!

 IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT THE PBM HELP DESK AT 1-800-648-0790                                   


 PLEASE MAKE THE FOLLOWING CHANGES TO THE 8/15/98 VERSION OF APPENDIX A:

 DRUG  DOSAGE STRGTH MAC EFF.DATE
EPIRUBICIN HCL VIAL 2MG/ML   10/02/99
ERYTHROMYCIN ESTOLATE CAPSULE 250MG OFF MAC 10/04/99
FOLIC ACID TABLET 1MG $0.03750 10/04/99
IBUPROFEN TABLET 400MG $0.16160  10/04/99
IBUPROFEN TABLET 600MG $0.22658 10/04/99
IBUPROFEN TABLET 800MG  $0.29020 10/04/99
 LINDANE   LOTION 1% 60'S  $0.09983 10/04/99
 LINDANE   LOTION 1% OTH SIZES OFF MAC 10/04/99
 LINDANE   SHAMPOO 1% 60'S $0.09983 10/04/99
 LINDANE   SHAMPOO 1% OTH SIZES OFF MAC 10/04/99
MINOXIDIL TABLET 2.5MG $0.33250 10/04/99
MINOXIDIL TABLET 10MG $0.54000 10/04/99
PIROXICAM CAPSULE 10MG $1.25750 10/04/99
PIROXICAM CAPSULE 20MG $2.15190 10/04/99
RAPACURONUM BROMIDE  VIAL  100MG    10/04/99
RANITIDINE HCL TABLET 150MG $1.47150  10/04/99
RANITIDINE HCL TABLET 300MG $2.56672 10/04/99
SOMATROPIN CARTRIDGE 0.2,0.4,0.6,0.8,1MG   10/02/99
VALPROIC ACID  CAPSULE  250MG  $0.59000 10/04/99

PLEASE FILE ADJUSTMENTS FOR CLAIMS WHICH MAY HAVE BEEN INCORRECTLY PAID


PHARMACY PROVIDERS

THE POS HELP DESK HAS RECEIVED INQUIRIES ASKING IF THE MEDICAID PAYMENT AND DOCUMENTATION METHODOLOGY FOR MAC DRUGS HAS CHANGED BECAUSE OF THE OCTOBER 1999 EDITION OF LOUISIANA BOARD OF PHARMACY NEWSLETTER.       

THE MESSAGE IS TO ADVISE PHARMACISTS THAT THE PAYMENT METHODOLOGY AND DOCUMENTATION REQUIREMENTS ON MAC DRUG PRICING HAS NOT CHANGED. PLEASE CONSULT THE PRESCRIPTION DRUG SERVICES MANUAL, PAGE 10-2 FOR A DISCUSSION OF BILLING REQUIREMENTS FOR MAC DRUGS.                           

"IN ACCORDANCE WITH FEDERAL REGULATIONS, MAC PRICES HAVE BEEN ASSIGNED FOR CERTAIN DRUGS....ANY DRUG WITH WHOLESALE COSTS EXCEEDING THE MAC  COSTS WILL BE REDUCED TO MAC LIMITATIONS.                             

WHEN A PHYSICIAN CERTIFIES THAT A SPECIFIC BRAND IS MEDICALLY NECESSARY FOR A PARTICULAR RECIPIENT,THEN THE MAC LIMITATIONS FOR THAT MEDICATION WILL NOT APPLY. THE FOLLOWING GUIDELINES WILL APPLY IN THESE CASES:    

A) THE CERTIFICATION MUST BE IN THE PHYSICIAN'S HANDWRITING,
B) THE CERTIFICATION MAY BE WRITTRN EITHER DIRECTLY ON THE PRESCRIPTION OR ON A SEPERATE SHEET WHICH IS ATTACHED TO THE PRESCRIPTION,
C) THE STANDARD PHRASES WRITTEN BY THE PRESCRIBER ON THE PRESCRIPTION SHOULD TESTIFY TO THE MEDICAL NECESSITY OF THE BRANDNAME DRUG. THE ONLY ACCEPTABLE PHRASES ARE 'BRAND NECESSARY' OR 'BRAND MEDICALLY NECESSARY' PHRASES SUCH AS 'DO NOT SUBSTITUTE','NO GENERICS' OR 'DISPENSE AS WRITTEN' ARE NOT ACCEPTABLE FOR OVERRIDING MAC LIMITATIONS. PROVIDERS  SHOULD VERIFY THAT THE APPROPRIATE WORDING IS PROPERLY DOCUMENTED AT THE TIME OF DISPENSING. CHECKING A PRINTED BOX ON THE PRESCRIPTION TO INDICATE THAT THE BRAND IS NECESSARY IS UNACCEPTABLE. A HANDWRITTEN STATEMENT TRANSFERRED TO A RUBBER STAMP AND THEN STAMPED ON THE PRESCRIPTION BLANK IS UNACCEPTABLE".                                   


NOTICE TO PROVIDERS

THE FOLLOWING CODES HAVE BEEN MADE PAYABLE FOR CROSSOVER CLAIMS EFFECTIVE WITH DATE OF SERVICE GIVEN:

G0125 PET LUNG EFFECTIVE WITH DATE OF SERVICE 4/01/1998
G0126 PET LUNG EFFECTIVE WITH DATE OF SERVICE 4/01/1998
G0163 PET COLORECTAL EFFECTIVE WITH DATE OF SERVICE 7/01/1998
G0164 PET LYMPHOMA EFFECTIVE WITH DATE OF SERVICE 7/01/1998
G0165 PET MELANOMA EFFECTIVE WITH DATE OF SERVICE 7/01/1998

NOTICE TO HOSPITALS

ON JULY 30, 1999, A MEMORANDUM WAS ISSUED REGARDING OUTPATIENT CODING FOR PPS DATA COLLECTION.  IF YOU ARE SUBMITTING A CPT/HCPCS WITH A REVENUE CODE, DO NOT SUBMIT THAT SAME REVENUE CODE WITHOUT A CPT/HCPCS ON THE SAME CLAIM FORM.  IF YOU DO, THE REVENUE CODE WITHOUT THE HCPCS WILL DENY.